Jeffrey Stein is CEO & President at Cidara Therapeutics, Inc. (CDTX). They have made 16 open-market trades across 2 companies since 2015, most recently 2026-03-02.
CIK 0001478831
16 open-market purchases totalling $4.9M since 2015, never a sale. Across 15 scored buys the stock is down 6.6% at ninety days, and 10.4 points behind the S&P over the same stretch.
15 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| IDYA | 54,281 | $1.8M |
| CDTX | 2,379 | $527K |
| PRTK | 68,625 | $153K |
| TSRX | 210,457 | — |
| Total | $2.5M |
Shares reported on the most recent Form 4, priced at the 2026-03-02 close. 1 holding could not be priced and is excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 40% | 47% |
| Avg Move | -3.8% | -3.2% | -6.6% |
| Alpha | -3.2% | -3.7% | -10.4% |
| Scored | 15 | 15 | 15 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IDYA | BUY | 2026-03-02 | 2026-03-02 | $32.96 | $1.6M | -7.0% | -7.9% | -18.0% |
| CDTX | BUY | 2024-06-07 | 2024-06-11 | $13.21 | $106K | -18.9% | -19.1% | -15.9% |
| CDTX | BUY | 2023-08-08 | 2023-08-08 | $0.96 | $48K | -17.8% | -0.4% | -19.2% |
| CDTX | BUY | 2023-03-27 | 2023-03-27 | $1.04 | $52K | +7.1% | -8.0% | -0.9% |
| PRTK | SELL · 10b5-1 | 2023-02-21 | 2023-02-23 | $1.90 | $13K | +5.0% | +5.6% | -1.7% |
| CDTX | BUY | 2021-11-12 | 2021-11-15 | $1.59 | $80K | -11.4% | -26.5% | -51.7% |
| CDTX | BUY | 2021-08-18 | 2021-08-19 | $1.73 | $87K | +27.1% | +15.5% | -11.0% |
| CDTX | BUY | 2020-11-10 | 2020-11-12 | $2.00 | $100K | -7.6% | -18.0% | +3.2% |
| CDTX | BUY | 2019-09-24 | 2019-09-26 | $1.91 | $100K | -4.8% | +6.5% | +42.5% |
| PRTK | SELL · 10b5-1 | 2019-02-15 | 2019-02-20 | $7.14 | $24K | -4.5% | -18.8% | -38.3% |
| CDTX | BUY | 2018-05-23 | 2018-05-24 | $4.70 | $2.0M | +1.7% | -9.6% | -24.3% |
| CDTX | BUY | 2017-09-12 | 2017-09-12 | $6.79 | $50K | +10.9% | +5.1% | +8.8% |
| CDTX | BUY | 2017-06-05 | 2017-06-07 | $5.95 | $89K | +14.3% | +21.8% | +17.6% |
| CDTX | BUY | 2017-03-31 | 2026-01-07 | $44.89 | $241K | N/A | N/A | N/A |
| CDTX | BUY | 2017-03-31 | 2017-04-04 | $7.75 | $100K | -9.7% | +0.0% | +4.8% |
| CDTX | BUY | 2016-05-20 | 2016-05-23 | $11.51 | $50K | -2.3% | -11.4% | +1.6% |
| CDTX | BUY | 2015-11-24 | 2015-11-27 | $15.09 | $101K | -19.6% | +2.3% | -38.2% |
| CDTX | BUY | 2015-04-20 | 2015-04-21 | $16.00 | $7K | -19.6% | +2.3% | +2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.